Crystal deal toy commmemorating a private placement for biopharmaceutical firm Palisade Bio. (24AKL340)
Crystal deal toy commmemorating a private placement for biopharmaceutical firm Palisade Bio. (24AKL340)
Crystal deal toy recognizing a follow-on public stock offering by Autonomix Medical. The Texas-based company specializes in technologies aimed at diagnosing and treating diseases involving the nervous systems. (24AKL507)
Custom Lucite celebrating the first-in-human trial of SOR 102, a treatment for nflammatory bowel disease. The drug was developed by Utah-based Sorriso Pharmaceuticals. (23AKL435)
Crystal financial tombstone celebrating Series B financing for Nuvig Therapeutics. The immune drug developer is based in Menlo Park, California. (24ALJ345)
Laboratory-themed crystal financial tombstone commemorating a capital raise by Sartorius Stedim Biotech. The biopharmaceutical company is based in Aubagne, France. (SO24LJW040)
Capsule-themed custom crystal commemoratng the first patient dosed stage in the development of ACR-2316. The cancer treatment was developed by Acrivon Therapeutics, a Watertown, Massachusetts-based biopharmaceutical company. (24AKL397)
Custom Lucite recognizing advances in the automated production of insulin secreting islet cells. (24AKL100)
Crystal financial tombstone celebrating the initial public offering of Emcure Pharmacuticals on the Bombay Stock Exchange and National Stock Exchange. The Pune, India-based drugmaker focuses on women’s healthcare. (24AKL301)
Crystal tombstone commemorting a private placement and a follow-on offering by Calidi Biotherapeutics. The San Diego-based company specializes in the development of cell-based therapies. (24AKL339)
